Seller record · Research vendor

Peptide Labs USA

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician evaluation is claimed anywhere on the site, and the stated purchase conditions are a minimum age of twenty one and a self-asserted research qualification. 3 more criteria also fail; see the table below.

At a glance

Peptide Labs USAResearch vendor

3/8criteria passed

Price: Printed on its own pages before sign-up
Sells: research peptides including BPC-157, CJC-1295 and cagrilintide, NAD+, and 4 more
FDA letters: None on file

Visit Peptide Labs USA See all eight dispositions

Research vendor. Passes 3 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A research peptide seller offering vials of NAD+, glutathione and repair peptides at prices printed on its catalog. Its checkout asks the buyer to agree to the terms of service of a differently named company, and the two are reconciled nowhere on the site.

Operating entity No legal entity name is printed in the footer, the contact page or the terms of service.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	FAIL	Peptide Labs USA's terms
S2	Prescription gating	FAIL	Peptide Labs USA's checkout
S3	Pharmacy identification	FAIL	Peptide Labs USA's terms
S4	Compounding disclosure	PASS	Peptide Labs USA's terms
S5	Analytical documentation	NOT VERIFIED	Peptide Labs USA's COA page
S6	Business address	FAIL	Peptide Labs USA's contact page
S7	Price disclosure	PASS	Peptide Labs USA's products page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1FAILNo clinician evaluation is claimed anywhere on the site, and the stated purchase conditions are a minimum age of twenty one and a self-asserted research qualification.Source: Peptide Labs USA's terms.

S2FAILA checkout collects full name, email, telephone and address with no eligibility question, starting from the NAD+ page at 59 dollars.Source: Peptide Labs USA's checkout.

S3FAILNo pharmacy is named anywhere on the site, and the terms sell every product for research use only.Source: Peptide Labs USA's terms.

S4PASSThe seller offers no compounded drug, and the terms state that the products are for lawful research use only and not for human consumption.Source: Peptide Labs USA's terms.

S5NOT VERIFIEDThe certificate documents behind the purity and endotoxin controls on the certificate page did not resolve, because those controls returned nothing when driven and expose no document address. The check is open.Source: Peptide Labs USA's COA page.

S6FAILNo street address appears in the footer, on the contact page or in the terms. The contact page offers a form and a telephone number, and the terms name a state of jurisdiction instead.Source: Peptide Labs USA's contact page.

S7PASSThe catalog prints prices with no account required, among them 59 dollars for NAD+ and figures from 39 dollars upward across the range.Source: Peptide Labs USA's products page.

S8PASSNo FDA warning letter names the storefront, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides including BPC-157, CJC-1295 and cagrilintide, NAD+, L-glutathione, AOD-9604, melanotan II, PT-141.

Other sellers of the same products

Who sells NAD+Who sells glutathione Who sells PT-141 Who sells BPC-157 Who sells cagrilintide

Visit Peptide Labs USA

535 sellers pass S1, prescriber requirement

See all 535 on the S1 criterion page — 527 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.